Study of a new drug for high triglycerides
Part of Hormones & metabolism clinical trials.
This early-stage trial tests an investigational drug called ISH0688 to see if it is safe and how well it works in people with high triglycerides (a type of fat in the blood). The study is also checking how the body absorbs and processes the drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old (this is for the later part of the study).
- Your fasting triglyceride level (a fat in your blood) must be high — 200 mg/dL or above.
- You cannot have had serious heart or blood vessel problems (like a heart attack or stroke) in the last 6 months.
- If you have diabetes, it must be well controlled, with an HbA1c level below 9.5%.
- You must be willing to follow strict rules about contraception (birth control) and not donate sperm or eggs for 6 months after the study ends.
- You must be able to have an MRI scan (a type of imaging that uses magnets) — this means no metal implants or other MRI problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, SHR-1918, to lower high triglyceride levels. It may be an option for people with moderately elevated triglycerides and controlled cholesterol.
This study tests a new drug, HRS-7249, to see if it safely lowers high triglyceride levels (a type of fat in the blood) that can increase the risk of heart problems. It is for people who either were in the earlier study of this drug or are new participants with high triglycerides.
This trial tests an investigational injection called SYH2070 to lower cholesterol and triglycerides in people who are already on a stable statin therapy. It may be a new option for those with mixed hyperlipidemia who need additional lipid control.
This study tests a new medicine called DR10624 to see if it can lower very high levels of triglycerides (a type of fat in the blood) in people who have not been helped enough by standard treatments. The study compares the new drug to a placebo (a dummy shot) over several months.
This first-in-human study tests an experimental drug (FXR0906) in healthy adults to see how safe it is and how the body processes it. The drug may one day help lower high triglycerides (fats in the blood).
This study tests an investigational medication called DR10624 for people with very high triglycerides, a type of fat in the blood that can increase the risk of heart problems and pancreatitis. The trial aims to see if this drug can safely lower triglycerides better than standard care.
Hear when a new Healthy Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.